Tom Gallen
Managing Editor, Europe
Latest From Tom Gallen
Futura's Eroxon Reaches 10 Countries In First Half Of 2024
France, Italy and Spain among the 10 countries where Futura Medical has rolled out its Eroxon drug-free erectile dysfunction treatment in the opening six months of the year.
Spain's Uriach Expands In Europe With Pascoe And Ineldéa
Consumer health manufacturer Uriach has agreed to acquire Germany's Pascoe Naturmedizin and through a separate transaction France's Laboratoires Ineldéa, following investment by private-equity firm ICG.
Alliance Pharma Books £46m Impairment Charge Related To US Menopause Supplement
Alliance Pharma has been hit by a non-cash impairment charge of £46.4m related to its Amberen dietary supplement reflecting the brand's struggles in the US e-commerce market.
Potential For Industry To Have Greater Involvement In EFSA Consultations
EFSA-commissioned report proposes changes to the way the authority conducts consultations on its scientific assessments which could give industry more opportunities for involvement.
People On The Move: Appointments At Arkopharma, PGEU, PLT
A round-up of the latest health and wellness industry moves: Arkopharma appoints chief executive officer, PGEU names leadership team for 2025; PLT Health hires China BD director.
Stada Bringing Histamine Intolerance Supplement To US
Germany's Stada has its eyes on expansion in the US dietary supplements market with the launch of histamine intolerance line Histasolv.